RebeccaLeighKingMD

PubMed

• 96 citations
  Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.
  Prashant Kapoor, Stephen M. Ansell, Rafael Fonseca, Asher Chanan-Khan, Robert A. Kyle
  JAMA Oncology. 2017-09-01
• 583 citations
  The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
  Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martinez, Steven H Swerdlow
  Blood. 2022-09-15
• 28 citations
  Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era.
  Arushi Khurana, Mattia Novo, Grzegorz S. Nowakowski, Kay M. Ristow, Robert J. Spinner
  Blood Advances. 2021-03-09

Abstracts/Posters

• Clinical Features and Treatment for Neurolymphomatosis in the Rituximab Era: Single Institution Experience
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytos...
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clustering of Transcriptomic Signatures in Newly Diagnosed Diffuse Large B-Cell Lymphoma Identifies Two High-Risk Subgroups Which Increase in Prevalence at Relapse
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Genomic Landscape Including Novel Mutational Drivers in Relapsed/Refractory Diffuse Large B Cell Lymphoma
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies
  Rebecca L. King, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all